Latest Trials

EudraCT Number: 2020-003146-36

Sponsor Protocol Number: RIAlta-1

Start Date: 2023-11-15

Sponsor Name: Vall d'Hebron Research Institute (VHIR)

Full Title: Safety of Rifampicin at High Dose for the Treatment of Adult Subjects with Complex Drug Susceptible Pulmonary and Extrapulmonary Tuberculosis

Medical condition: Pulmonary and extrapulmonary tuberculosis

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing) ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2020-003804-15

Sponsor Protocol Number: SGMCBM

Start Date: 2023-11-09

Sponsor Name: Leiden University Medical Center

Full Title: A FEASIBILITY STUDY OF SGM-101, A FLUOROCHROME-LABELED ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY FOR THE INTRAOPERATIVE DETECTION OF COLORECTAL BRAIN METASTASES

Medical condition: Colorectal brain metastases

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10052358	Colorectal cancer metastatic	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10055093	Brain cancer metastatic	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2022-001632-28

Sponsor Protocol Number: GENTLE

Start Date: 2023-10-24

Sponsor Name: Rijnstate

Full Title: Ghrelin in anterior circulation stroke and EVT

Medical condition: acute ischemic stroke

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2022-003318-35

Sponsor Protocol Number: VX22-264-101

Start Date: 2023-09-25

Sponsor Name: Vertex Pharmaceuticals Incorporated

Full Title: A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of VX-264 in Subjects With Type 1 Diabetes Mellitus

Medical condition: Type 1 Diabetes Mellitus

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10027433 - Metabolism and nutrition disorders	10012601	Diabetes mellitus	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Ongoing) NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2022-001287-10

Sponsor Protocol Number: NBK241/2/2022

Start Date: 2023-09-22

Sponsor Name: Gdański Uniwersytet Medyczny

Full Title: Treatment of acute ischemic stroke due to occlusion of a large vessel by mechanical thrombectomy in patients with unknown onset or not meeting the criteria for CT eligibility (ASPECTS

Medical condition: acute ischemic stroke caused by occlusion of a large vessel

Disease:	Version	SOC Term	Classification Code	Term	Level
	23.1	10029205 - Nervous system disorders	10084836	Malignant ischemic stroke	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: PL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2022-004078-53

Sponsor Protocol Number: 83403

Start Date: 2023-08-22

Sponsor Name: Academic Medical Center (AMC), department of Internal Medicine

Full Title: Specifying the anti-inflammatory effects of ziltivekimab with diverse imaging modalities and in-depth cellular phenotyping

Medical condition: - Plaque characteristics - Systemic inflammation

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2020-003063-26

Sponsor Protocol Number: 1634

Start Date: 2023-08-10

Sponsor Name: European Organisation for Research and Treatment of

Full Title: Personalized Risk-Adapted Therapy in Post-Pubertal Patients with Newly Diagnosed Medulloblastoma (PersoMed-I)

Medical condition: Newly Diagnosed Medulloblastoma

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10027107	Medulloblastoma	PT

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: AT (Ongoing) DE (Ongoing) IT (Ongoing) NL (Ongoing) ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2022-001063-27

Sponsor Protocol Number: JZP385-202-01

Start Date: 2023-07-19

Sponsor Name: Cavion, Inc., a subsidiary of Jazz Pharmaceuticals, Inc.

Full Title: A 17-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Flexible-dosing, Parallel-group, Multicenter Study of the Efficacy and Safety of Suvecaltamide in the Treatment of Moderate to Seve...

Medical condition: Parkinson’s Disease

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10029205 - Nervous system disorders	10061536	Parkinson's disease	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Ongoing) ES (Ongoing) PL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2022-002788-30

Sponsor Protocol Number: IMVT-1401-3202

Start Date: 2023-07-13

Sponsor Name: Immunovant Sciences, GmbH

Full Title: A Phase 3, Multi-center, Randomized, Quadruple-masked, Placebo-controlled Study of Batoclimab for the Treatment of Participants with Active Thyroid Eye Disease (TED)

Medical condition: Thyroid Eye Disease (TED)

Disease:	Version	SOC Term	Classification Code	Term	Level
	23.1	100000004853	10084358	Thyroid eye disease	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Ongoing) BE (Ongoing) LV (Ongoing) HU (Ongoing) SK (Ongoing) ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2020-004917-10

Sponsor Protocol Number: TIGER

Start Date: 2023-06-29

Sponsor Name: King's College London [...] 1. King's College London 2. King's College Hospital NHS Foundation Trust

Full Title: Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative age-Related macular degeneration (TIGER): a phase 3, pan-European, two-gro...

Medical condition: Submacular haemorrhage secondary to exudative age-related macular degeneration

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	100000004853	10075718	Exudative age-related macular degeneration	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Trial now transitioned)

Trial results: (No results available)

Latest Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions